Speaker illustration

Doctor Marta Gil Fernandez

Investigation Institute la PAZ University Hospital, IdiPAZ, Madrid (Spain)

Member of:

European Society of Cardiology

Biomedical scientist with a PhD in Molecular Biosciences and international experience in translational cardiovascular research. Specialized in innate immunity, calcium signaling, and atrial remodeling, with first-author publications in high-impact journals (e.g., JACC: BTS, IJMS, Acta Physiologica). Strong background in molecular pharmacology, animal models, and cardiac inflammation. Awarded multiple grants and honors, including ESC travel and poster awards. Currently a postdoctoral researcher at IdiPAZ, contributing to nationally funded projects on innate immune signaling and heart failure. Experienced in scientific communication, teaching, and AI-enhanced research workflows. Completed a PhD research stay at Baylor College of Medicine (USA). Highly motivated to contribute to cardiac science through collaborative, patient-oriented research.

NOD1 as a key mediator of atrial remodelling in heart failure

Event: ESC Congress 2025

Topic: Heart Failure

Session: Molecular mechanisms and metabolic remodelling in heart failure

Thumbnail

Role of NOD1 in atrial myopathy associated with heart failure

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Heart Failure

Session: Bed to bench and back: arrhythmogenic cardiomyopathy translating disease mechanisms into novel therapy

Thumbnail

RIP2 plays a role in cardiac Ca2+ mishandling prompted by chronic kidney disease

Event: ESC Congress 2020

Topic: Ion Channels, Electrophysiology

Session: Basic Science Cardiac ePosters

Thumbnail